William D Chey, MD, FACG, AGAF, FACP, RFF
H Marvin Pollard Professor of Gastroenterology
Professor of Internal Medicine
Section Head, Division of Gastroenterology
Medical School and Professor of Nutritional Sciences
School of Public Health

Available to mentor

William D Chey, MD, FACG, AGAF, FACP, RFF
Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile
    About

    Dr. Chey received his BA degree from the University of Pennsylvania and medical degree & training in internal medicine at the Emory University School of Medicine. He went on to complete a fellowship in gastroenterology at the University of Michigan. Since completing this fellowship, Dr. Chey has remained at the University of Michigan, where he is H. Marvin Pollard Professor of Gastroenterology, Professor of Nutrition Sciences, and Chief, Division of Gastroenterology & Hepatology. Dr. Chey runs a very active clinical research group which has received funding from federal and private sources. Dr. Chey has authored more than 400 manuscripts, reviews and book chapters yielding an H-index of 50. He is former Co-editor-in-Chief of the American Journal of Gastroenterology (2010-2016) and serves on the editorial boards of several other journals. He serves as a member of the Board of Trustees and in 2026, will become President of the American College of Gastroenterology. He is a member of the Board of Directors of the Rome Foundation and IFFGD. He has participated in and directed numerous national and international continuing medical education programs in gastroenterology, and has been elected to the roster of Best Doctors since 2001 and America's™ Top Doctors since 2009. Dr. Chey has received numerous awards including the Berk-Fise Award for outstanding clinical service from the ACG, the Distinguished Clinician Award from the AGA, Dean’s Outstanding Clinician Award, Dean’s Award for Innovation and Commercialization, and the Healio Disruptive Innovator Award.

    Qualifications
    • MD
      Emory University Medical School, 1986
    • BA
      University of Pennsylvania, 1982
    Center Memberships
    • Center Member
      Precision Health Initiative
    Research Overview

    Diagnosis and treatment of irritable bowel syndrome (IBS), constipation, fecal incontinence; gastroesophageal reflux disease (GERD), and "H. pylori" infection.

    Recent Publications See All Publications
    • Journal Article
      Why Symptoms Linger in Quiescent Crohn’s Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways
      Golob J, Rao K, Berinstein JA, Singh P, Chey WD, Owyang C, Kamada N, Higgins PDR, Young V, Bishu S, Lee AA. Inflammatory Bowel Diseases, 2025 Mar 20; 31 (3): 763 - 776. DOI:10.1093/ibd/izae238
    • Journal Article
      All FODMAPs Aren't Created Equal: Results of a Randomized Reintroduction Trial in Patients With Irritable Bowel Syndrome
      Eswaran S, Jencks KJ, Singh P, Rifkin S, Han-Markey T, Chey WD. Clinical Gastroenterology and Hepatology, 2025 Mar 20; 23 (2): 351 - 358.e5. DOI:10.1016/j.cgh.2024.03.047
    • Journal Article
      Is a Simplified, Less Restrictive Low FODMAP Diet Possible? Results From a Double-Blind, Pilot Randomized Controlled Trial
      Singh P, Chey SW, Nee J, Eswaran S, Dean G, Iturrino J, Rangan V, Lembo A, Chey WD. Clinical Gastroenterology and Hepatology, 2025 Mar 20; 23 (2): 362 - 364.e2. DOI:10.1016/j.cgh.2024.04.021
    • Journal Article
      Missed Opportunity to Triage Patients With Irritable Bowel Syndrome to Multidisciplinary Therapy
      Tetali B, Chey WD, Menees SB. Clinical Gastroenterology and Hepatology, 2025 Feb 1; 23 (2): 371 - 373.e1. DOI:10.1016/j.cgh.2024.08.019
      PMID: 39209195
    • Journal Article
      A Novel, IBS-Specific IgG ELISA-Based Elimination Diet in Irritable Bowel Syndrome: A Randomized, Sham-Controlled Trial.
      Singh P, Chey WD, Takakura W, Cash BD, Lacy BE, Quigley EMM, Randall CW, Lembo A. Gastroenterology, 2025 Mar 20; DOI:10.1053/j.gastro.2025.01.223
    • Journal Article
      Re-evaluating the Proposed Association Between Vonoprazan and Gastric Cancer Following Eradication of H. pylori Infection
      Howden CW, Chey WD, Shah SC. Clinical Gastroenterology and Hepatology, 2025 Jan 1; 23 (1): 182 - 183. DOI:10.1016/j.cgh.2024.04.015
      PMID: 38729385
    • Journal Article
      The Assessment of Gastrointestinal Transit by the Atmo Capsule: A Comparison With the SmartPill Capsule
      Kuo B, Lee AA, Abell T, Attaluri A, Cline M, Hasler W, Ho V, Lembo AJ, Masoud A, McCallum R, Moshiree B, Quigley EMM, Rao SSC, Stocker A, Sanchez M, Sarosiek I, Surjanhata B, Zhou J, Chey WD. Clinical Gastroenterology and Hepatology, 2025 Jan 1; DOI:10.1016/j.cgh.2024.12.013
      PMID: 39889900
    • Journal Article
      The Vibrating Capsule: Safety and Tolerability in Patients With Chronic Idiopathic Constipation
      Curtin BF, Quigley EMM, Chey WD, Lembo AJ, Brenner DM, Spiegel BMR, Rao SSC. Neurogastroenterology and Motility, 2025 Jan 1; DOI:10.1111/nmo.15004
      PMID: 40059867
    Featured News & Stories father and son standing together and book cover
    Health Lab
    One doctor’s American dream: to stop hate
    Asian-American history is American history. William D. Chey shares his immigrant father’s legacy, his own experience and calls on youth to practice the values of diversity, equity and inclusion throughout their lives.
    bent over holding stomach pink shirt sitting
    Health Lab
    FDA approves gastrointestinal device
    The FDA approved a device developed at the University of Michigan that allows doctors to diagnose and predict treatment outcomes for individuals with chronic constipation far earlier than other methods.
    bacteria blue yellow
    Health Lab
    New guideline for Helicobacter pylori includes change to primary treatment recommendation
    The American Journal of Gastroenterology has published a new guideline on the treatment of Helicobacter pylori (H. pylori) Infection.